Have we presented any amendments? No.
Are we happy with the law as written? Yes.
Do we acknowledge that there could be some legitimate exemptions—like maybe from our colleagues here—that should be considered? Sure. I'm not an expert in medical technology, so I wouldn't try to speak for them.
I would say two things about any exemption process that the committee might consider through amendment. The first is that every industry will line up and claim that it is worthy of an exemption. Some will actually be worthy; some may be less worthy.
I think this committee probably hears from the brand name and generic pharmaceutical industries from time to time. You will know that they just spend all their time in court arguing over how long various periods should be. I would hope the committee would want to avoid that in any amendments it might consider on this bill. Think carefully about how to narrow the possibility of getting an exemption.
If I may, sir, there was a prior testimony that perhaps those who want to circumvent a digital lock should have to make their case. I would suggest the onus should be the other way around. If you are about to pass a law of general applicability that allows for the circumvention of digital locks for legitimate purposes, it should be the industry that says that we can't touch its software that should have to make its case.
Thank you.